IDEXX Reference Laboratories
A comprehensive approach for itchy patients
Multiple tools to assist in the diagnosis of itchy patients
Regionally specific panels to assist in the formulation of immunotherapy
Immunotherapy in either sublingual and subcutaneous administration
Complimentary expert consultations with a board-certified dermatologist.
Sarcoptes Antibody ELISA
The Sarcoptes Antibody ELISA helps confirm or rule out a suspicion of sarcoptic mange in dogs based on clinical signs. The condition is currently diagnosed by skin scraping but most often confirmed through response to treatment.
Ringworm RealPCR Panel
With the Ringworm RealPCR Panel, you get accurate results faster than the dermatophyte test media (DTM) plate. Results from this test are available in 1–3 working days.
Aller-g-detect Allergen Preliminary Panel
Aller-g-detect Allergen Preliminary Panel provides a low-cost serum test that detects allergen-specific antibodies against four common allergen groups: mites/moulds, grasses, weeds and trees. Use this panel to confirm if your patient is a good candidate for immunotherapy through IDEXX.
Allergen Panel (Standard Regional, Insect, Food, Farm & Stable)
Eight regionally specific panels ensure you are testing for only the most relevant allergens in your area and none that are not. Use this . We also offer allergen panels for insect, farm and stable, food and .
Allergen-specific immunotherapy (ASIT) is the only available treatment that may change the long-term course of the disease in your atopic patients. IDEXX offers subcutaneous immunotherapy compounded Artuvet Animal Health and delivered within 1 week.
Your team of experts is just a call away, with pathologists always available for consultation.
0203 7887 508
Forms & other resources
Access IDEXX Reference Laboratories specimen guidelines, forms, articles, and more.
Laboratory Test Menu
Browse the online Laboratory Test Menu to see a comprehensive list of offerings from IDEXX Reference Laboratories.
PCR testing is a service performed pursuant to an agreement with Roche Molecular Systems, Inc.